Padcev, a drug Pfizer acquired in 2023, is a part of the only chemo-free treatment for bladder cancer patients newly ...

Pfizer's high initial dividend yield, solid ratings, and promising pipeline make it a potentially undervalued investment. See ...

Maintaining dividend aristocrat status isn’t easy, as it requires companies to pay out dividends consistently (and raise them ...

Investors looking for a way to pump up their passive income streams want to turn their attention toward the pharmaceutical ...

I have selected Pfizer and Verizon as my top two high dividend yield companies to invest in for November 2024. Click here to ...

Dividend stocks provide investors with reliable passive income. These four health care picks look like outstanding ideas now.

Political uncertainty has created buying opportunities among blue-chip healthcare stocks with big-time dividends.

We recently compiled a list of the Dividend Contenders List: Top 15. In this article, we are going to take a look at where Pfizer Inc. (NYSE:PFE) stands against the other dividend contenders.

The proliferation of a less fatal strain of Covid hurt prospects for both Pfizer (PFE) and especially Moderna (MRNA).

Now and then, though, I stumble across high-yielding dividend stocks that aren’t yield traps. I believe that one such example is Pfizer (PFE). Interestingly, Pfizer’s 5.9% dividend yield is ...